Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Etienne Becht

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene AlterationsAudrey Mansuet-Lupo, Marco Alifano, Nicolas Pécuchet, et al.
JHEP Reports : Innovation in Hepatology|October 20, 2025
PSMA immunohistochemistry as a diagnostic biomarker of hepatocellular carcinomaKillian Véron, Etienne Becht, Astrid Laurent-Bellue, et al.
Frontiers in Immunology|April 22, 2025
Glucose deprivation and identification of TXNIP as an immunometabolic modulator of T cell activation in cancerAgathe Dubuisson, Adèle Mangelinck, Samantha Knockaert, et al.
Cancer Research|February 5, 2016
Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable PrognosisJitka Fucikova, Etienne Becht, Kristina Iribarren, et al.
European Urology Focus|July 30, 2017
PD-L1 Expression and CD8<sup>+</sup> T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate CancerFlorent Petitprez, Nicola Fossati, Yann Vano, et al.
Oncotarget|June 17, 2015
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancerMichal Podrazil, Rudolf Horvath, Etienne Becht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2017
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell CarcinomaNicolas A Giraldo, Etienne Becht, Yann Vano, et al.
Nature Communications|July 15, 2025
Pregnancy-acquired memory CD4<sup>+</sup> regulatory T cells improve pregnancy outcome in miceKristin Thiele, Christopher Urbschat, Julia Isabel Amambay Riquelme, et al.
Oncoimmunology|May 4, 2018
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcomeVéronique M Braud, Jérôme Biton, Etienne Becht, et al.
Nature Communications|November 6, 2019
Author Correction: Lung endothelial cell antigen cross-presentation to CD8<sup>+</sup>T cells drives malaria-associated lung injuryCarla Claser, Samantha Yee Teng Nguee, Akhila Balachander, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Intratumoral Immune Cell Densities Are Associated with Lung Adenocarcinoma Gene AlterationsAudrey Mansuet-Lupo, Marco Alifano, Nicolas Pécuchet, et al.
JHEP Reports : Innovation in Hepatology|October 20, 2025
PSMA immunohistochemistry as a diagnostic biomarker of hepatocellular carcinomaKillian Véron, Etienne Becht, Astrid Laurent-Bellue, et al.
Frontiers in Immunology|April 22, 2025
Glucose deprivation and identification of TXNIP as an immunometabolic modulator of T cell activation in cancerAgathe Dubuisson, Adèle Mangelinck, Samantha Knockaert, et al.
Cancer Research|February 5, 2016
Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable PrognosisJitka Fucikova, Etienne Becht, Kristina Iribarren, et al.
European Urology Focus|July 30, 2017
PD-L1 Expression and CD8<sup>+</sup> T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate CancerFlorent Petitprez, Nicola Fossati, Yann Vano, et al.
Oncotarget|June 17, 2015
Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancerMichal Podrazil, Rudolf Horvath, Etienne Becht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2017
Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell CarcinomaNicolas A Giraldo, Etienne Becht, Yann Vano, et al.
Nature Communications|July 15, 2025
Pregnancy-acquired memory CD4<sup>+</sup> regulatory T cells improve pregnancy outcome in miceKristin Thiele, Christopher Urbschat, Julia Isabel Amambay Riquelme, et al.
Oncoimmunology|May 4, 2018
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcomeVéronique M Braud, Jérôme Biton, Etienne Becht, et al.
Nature Communications|November 6, 2019
Author Correction: Lung endothelial cell antigen cross-presentation to CD8<sup>+</sup>T cells drives malaria-associated lung injuryCarla Claser, Samantha Yee Teng Nguee, Akhila Balachander, et al.
Pageof 7